Michael Cruse Reneo Pharmaceuticals, Inc. (RPHM) insider trading activity

RPHM Quotes by TradingView

Michael Cruse is Chief Operating Officer of Reneo Pharmaceuticals, Inc.. Currently has a direct ownership of 31,758 shares of RPHM, which is worth approximately $53,353. The most recent transaction as insider was on Aug 30, 2022, when has been sold 975 shares (Common Stock) at a price of $3.16 per share, resulting in proceeds of $3,081. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 31.8K
0% 3M change
0% 12M change
Total Value Held $53,353

Michael Cruse Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 30 2022
BUY
Open market or private purchase
$3,081 $3.16 p/Share
975 Added 2.98%
31,758 Common Stock
Aug 29 2022
BUY
Open market or private purchase
$269 $3.24 p/Share
83 Added 0.27%
30,783 Common Stock
Dec 10 2021
BUY
Grant, award, or other acquisition
-
25,000 Added 46.21%
29,100 Common Stock
Aug 25 2021
BUY
Open market or private purchase
$18,625 $7.45 p/Share
2,500 Added 50.0%
2,500 Common Stock
MC

Michael Cruse

Chief Operating Officer
Irvine, CA

Track Institutional and Insider Activities on RPHM

Follow Reneo Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RPHM shares.

Notify only if

Insider Trading

Get notified when an Reneo Pharmaceuticals, Inc. insider buys or sells RPHM shares.

Notify only if

News

Receive news related to Reneo Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RPHM